Cansativa Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany
August 9, 2022
FRANKFURT AM MAIN & LONDON–(BUSINESS WIRE)– Akanda Corp. (“Akanda”) (NASDAQ: AKAN) and Cansativa GmbH (“Cansativa Group”) today jointly announced a new cooperation that […]
Akanda to Supply Cansativa with Premium Indoor Cannabis Flower Grown at its Sintra Facility in Portugal
August 9, 2022
Agreement generates upfront payment and ongoing revenues, validating the European opportunity for medical cannabis LONDON–(BUSINESS WIRE)– International medical cannabis platform company Akanda Corp. […]
Akanda to Contest Unauthorized Liquidation of its Lesotho-Based Subsidiary, Bophelo Bio Science & Wellness (Pty) Ltd.
July 26, 2022
Executive Chairman Louisa Mojela Terminated for Cause LONDON–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis platform company, […]
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
July 12, 2022
Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products Diversifies Akanda into cancer […]
Akanda’s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK
June 29, 2022
LONDON–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and […]
Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting
June 23, 2022
TORONTO–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”) today announced certain changes to its board of directors (the “Board”) and the postponement of […]
Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA)
May 2, 2022
Adds prized cultivation, manufacturing and distribution assets and an award-winning genetics library, accelerating Akanda’s seed-to-patient model LONDON–(BUSINESS WIRE)– International medical cannabis company Akanda […]
Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access
April 20, 2022
Transformational deal will add prized cultivation, manufacturing and distribution assets to accelerate Akanda’s seed-to-patient model and satisfy demand in fast-growing European cannabis […]
Akanda Corp. Announces Pricing of Initial Public Offering
April 14, 2022
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced the pricing of its initial public offering of […]
Akanda Corp. Closes Initial Public Offering
March 17, 2022
LONDON–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced the completion of its initial public offering of […]
Akanda Corp. Common Shares Set to Commence Trading Today on Nasdaq Under Ticker Symbol “AKAN”
March 15, 2022
LONDON–(BUSINESS WIRE)– Akanda Corp (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today announced the Company’s common shares are scheduled […]
Akanda Corp. Closes Its First Day of Trading on The NASDAQ Capital Market
March 15, 2022
LONDON–(BUSINESS WIRE)– Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today commenced the trading of its common shares […]